Prevalence and treatment of central sleep apnoea emerging after initiation of continuous positive airway pressure in patients with obstructive sleep apnoea without evidence of heart failure |
| |
| Authors: | Michael Westhoff Michael Arzt Patric Litterst |
| |
| Institution: | (1) Department of Pulmonary, Critical Care and Sleep Medicine, Hemer Lung Clinic, Theo-Funccius-Str. 1, 58675 Hemer, Germany;(2) Center for Sleep Medicine, Department of Internal Medicine II, Division of Respirology, University of Regensburg, Regensburg, Germany;(3) Lungenklinik Hemer, Theo-Funccius-Str. 1, 58675 Hemer, Germany |
| |
| Abstract: | Background This study aimed to assess the prevalence of complex sleep apnoea (CompSA), defined as central sleep apnoea (CSA) emerging
after the initiation of continuous positive airway pressure (CPAP) therapy for obstructive sleep apnoea (OSA), in patients
with normal brain natriuretic peptide (BNP) levels, along with assessing the prevalence of CSA persisting in such patients
after the onset of CPAP therapy. We hypothesised that the prevalence of CompSA and persistent CSA after CPAP initiation would
be low in patients with OSA and normal BNP levels. |
| |
| Keywords: | |
| 本文献已被 SpringerLink 等数据库收录！ |
|
